Please use this identifier to cite or link to this item: https://doi.org/10.1038/sj.gt.3302771
DC FieldValue
dc.titleAstrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter
dc.contributor.authorWang, C.Y.
dc.contributor.authorWang, S.
dc.date.accessioned2014-10-27T08:22:19Z
dc.date.available2014-10-27T08:22:19Z
dc.date.issued2006-10
dc.identifier.citationWang, C.Y., Wang, S. (2006-10). Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Therapy 13 (20) : 1447-1456. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.gt.3302771
dc.identifier.issn09697128
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/100129
dc.description.abstractTherapeutic gene expression in glial cells has been tested for the treatment of neurological diseases in animal models. Many of such studies used the promoter of the glial fibrillary acidic protein (GFAP) to restrict gene expression to astrocytes. We have investigated in the current study whether it is possible to improve the transcriptional activity of the cellular promoter, while maintaining its cell-type specificity. We constructed an expression cassette containing a hybrid cytomegalovirus (CMV) enhancer/GFAP promoter and placed it into baculovirus vectors, a type of viral vectors capable of transducing astrocytes. In another vector design, we used inverted terminal repeats (ITRs) from adeno-associated virus (AAV) to flank the expression cassette. The recombinant baculoviruses with the hybrid promoter improved gene expression levels over two orders of magnitude in glial cell lines and by 10-fold in the rat brain when compared to the baculoviruses with the GFAP promoter alone. The expression was further improved by ITR flanking, reaching levels higher than that mediated by the baculovirus vectors with the CMV immediate-early enhancer/promoter (CMV promoter). Using these recombinant baculoviruses, we observed extended in vivo transgene expression in the rat brain at 90 days postinjection, by which time the gene expression from baculovirus vectors with the GFAP or CMV promoter had already become undetectable. The astrocyte specificity of the GFAP promoter was preserved in the engineered expression cassette with the CMV enhancer and the AAV ITRs, as demonstrated by immunohistological analysis of brain samples and an axonal retrograde transport assay. Taken together, our findings suggest that these baculovirus vectors may serve as useful tools for astrocyte-specific gene expression in the brain.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/sj.gt.3302771
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.description.doi10.1038/sj.gt.3302771
dc.description.sourcetitleGene Therapy
dc.description.volume13
dc.description.issue20
dc.description.page1447-1456
dc.description.codenGETHE
dc.identifier.isiut000240942800003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

47
checked on Jul 16, 2020

WEB OF SCIENCETM
Citations

42
checked on Jul 16, 2020

Page view(s)

89
checked on Jul 12, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.